X-Chem Overview

  • Founded
  • 2009
Founded
  • Status
  • Private
  • Employees
  • 47
Employees
  • Latest Deal Type
  • Debt Refin.
  • Financing Rounds
  • 6
  • Investments
  • 1

X-Chem General Information

Description

Provider of biotechnological services. The company's biotechnological services include drug discovery generated by iterative combinatorial synthesis of small molecules tethered to DNA tags that record the synthetic history of the small molecule.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
  • 100 Beaver Street
  • Waltham, MA 02453
  • United States
+1 (781) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

X-Chem Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore X-Chem‘s full profile, request access.

Request a free trial

X-Chem Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Provider of biotechnological services. The company's biotechnological services include drug discovery generated by itera
Drug Discovery
Waltham, MA
47 As of 2014
000000000 00

0-00000

re et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi u
0000000000000
Seattle, WA
00 As of 0000
000.00
0000 0000-00-00
00000000000 000.00

00000000

aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Ex
0000 000000000
San Diego, CA
000 As of 0000
00000
0.00 0000-00-00
000000&0 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

X-Chem Competitors (18)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
A-Alpha Bio Venture Capital-Backed Seattle, WA 00 000.00 00000000000 000.00
00000000 000000000 Venture Capital-Backed San Diego, CA 000 00000 000000&0 00000
00000000 Venture Capital-Backed Essex, United Kingdom 00 000 00000000000 000
000000 00000000000 Corporation Cambridge, MA 000 00000 000000 - 000 00000
00000000 000000000 Venture Capital-Backed Uppsala, Sweden 00 0000000000
You’re viewing 5 of 18 competitors. Get the full list »

X-Chem Executive Team (14)

Name Title Board Seat Contact Info
Matthew Clark Ph.D Chief Executive Officer
Terry Loding Chief Operating Officer & Head of Strategy
Steffen Helmling Ph.D Chief Business Officer
Ying Zhang Ph.D Senior Director, Discovery Chemistry
Anthony Keefe Ph.D Senior Vice President, Innovation
You’re viewing 5 of 14 executive team members. Get the full list »

X-Chem Board Members (8)

Name Representing Role Since
0000000 00 00000 Pharmaceutical Product Development Board Member 000 0000
0000 0000000 X-Chem Chairman 000 0000
You’re viewing 2 of 8 board members. Get the full list »

X-Chem Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

X-Chem Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore X-Chem‘s full profile, request access.

Request a free trial

X-Chem Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000000 000000 26-Jan-2021 0000000000 BPO/Outsource Services 0000000 00000 00.0
To view X-Chem’s complete investments history, request access »